Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis by Cindy B. McReynolds, Cindy B. McReynolds, Sung Hee Hwang, Sung Hee Hwang, Jun Yang, Jun Yang, Debin Wan, Karen Wagner, Karen Wagner, Christophe Morisseau, Dongyang Li, William K. Schmidt, Bruce D. Hammock, Bruce D. Hammock

Get full text

Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections by Cindy B. McReynolds, Cindy B. McReynolds, Irene Cortes-Puch, Irene Cortes-Puch, Irene Cortes-Puch, Resmi Ravindran, Imran H. Khan, Bruce G. Hammock, Pei-an Betty Shih, Bruce D. Hammock, Bruce D. Hammock, Bruce D. Hammock, Jun Yang, Jun Yang

Get full text

Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development by Cindy B. McReynolds, Jun Yang, Alonso Guedes, Christophe Morisseau, Roberto Garcia, Heather Knych, Caitlin Tearney, Briana Hamamoto, Sung Hee Hwang, Karen Wagner, Bruce D. Hammock

Get full text

In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea by Debin Wan, Jun Yang, Cindy B. McReynolds, Bogdan Barnych, Karen M. Wagner, Christophe Morisseau, Sung Hee Hwang, Jia Sun, Jia Sun, René Blöcher, Bruce D. Hammock

Get full text

The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling by Ailin Luo, Zifeng Wu, Shan Li, Cindy B. McReynolds, Di Wang, Hanyu Liu, Chaoli Huang, Teng He, Xinying Zhang, Yuanyuan Wang, Cunming Liu, Bruce D. Hammock, Kenji Hashimoto, Chun Yang

Get full text